brentuximab,Dacarbazine,Doxorubicin Hydrochloride,Filgrastim,Nivolumab,Pegfilgrastim,Vinblastine Sulfate
seagen,amgen,Bms
['nivolumab', 'brentuximab', 'lymphoma', 'nivo', 'hodgkin']
asco 2023: nivolumab reduces risk of disease progression or death in untreated hodgkin lymphoma compared to brentuximab - ecancer 
PEADIATRICIAN HEMATOLOGIST ONCOLOGIST
MD, PhD
Consultant at MITERA HOSPITAL